ZapA, a virulence factor in a rat model of Proteus mirabilis-induced acute and chronic prostatitis

Van Phan1, Robert Belas, Brendan F Gilmore

  • 1Biofilm Research Group, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada T2N 1N4.

Infection and Immunity
|August 30, 2008
PubMed

Insights

Proteus mirabilis metalloproteinase ZapA is crucial for causing acute and chronic prostatitis in rats. Deleting ZapA significantly reduced disease severity and allowed bacterial clearance, highlighting its role in pathogenesis.

Area of Science:

  • Microbiology
  • Pathogenesis
  • Urology

Background:

  • Understanding virulence factors is key to studying disease pathogenesis.
  • Proteus mirabilis is a common cause of urinary tract infections, including prostatitis.

Purpose of the Study:

  • To investigate the role of the metalloproteinase ZapA from Proteus mirabilis in the development of prostatitis.
  • To determine if ZapA is essential for both acute and chronic prostatitis.

Main Methods:

  • Rats were infected with wild-type (WT) P. mirabilis or its isogenic ZapA-deficient mutant (ZapA(-)).
  • Histological analysis and bacterial colonization levels were assessed to evaluate prostatitis severity.
  • In vitro biofilm formation capacity of the mutant was tested.

Main Results:

  • WT P. mirabilis infection led to acute and chronic prostatitis with characteristic histological changes.
  • Infection with the ZapA(-) mutant resulted in significantly reduced acute prostatitis, evidenced by less tissue damage, lower bacterial load, and decreased inflammation.
  • The ZapA(-) mutant was unable to establish chronic infection, with bacteria being cleared and prostate tissue healing.
  • The reduced virulence of the ZapA(-) mutant was not due to impaired in vitro biofilm formation.

Conclusions:

  • ZapA is a critical virulence factor for Proteus mirabilis in establishing both acute and chronic bacterial prostatitis.
  • Targeting ZapA may be a potential therapeutic strategy for prostatitis.